Metraipolis › archive › dc_ce8249d83c7a

Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy — Europe PMC PMID:42764979

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42764979
DOI
10.1016/j.mtbio.2026.103664
License (as archived)
solo-consultazione
Archived
2026-10-10T05:05:07.180Z
SHA-256 of the archived text
4e05483662372616dec8798fad76f9028891143b598f4f32eb6ff046145890f2
Stable URL of this page
https://metraipolis.com/documento/dc_ce8249d83c7a

How to cite

Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy — Europe PMC PMID:42764979 — Europe PMC (en), https://europepmc.org/article/MED/42764979 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ce8249d83c7a (Metraipolis archive dc_ce8249d83c7a, sha256 4e05483662372616dec8798fad76f9028891143b598f4f32eb6ff046145890f2)
BibTeX
@misc{dcce8249d83c7a,
  title = {Biomaterial engineering of the tumor glycocalyx for cancer immunotherapy — Europe PMC PMID:42764979},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42764979},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ce8249d83c7a; sha256 4e05483662372616dec8798fad76f9028891143b598f4f32eb6ff046145890f2},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42764979. Agents can read the archived copy with the MCP tool read_document.